Yun Zhong
Stock Analyst at Wedbush
(0.07)
# 4,555
Out of 4,596 analysts
419
Total ratings
37.7%
Success rate
-9.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yun Zhong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCKT Rocket Pharmaceuticals | Maintained: Buy | $16 | $3.31 | +383.38% | 22 | Aug 3, 2026 | |
| WVE Wave Life Sciences | Rated: Buy | $15 → $12 | $5.55 | +116.22% | 21 | Jul 31, 2026 | |
| MNKD MannKind | Maintained: Buy | $8 | $3.87 | +106.72% | 26 | Jul 30, 2026 | |
| BNTC Benitec Biopharma | Initiated Coverage: Buy | $16 | $11.72 | +36.52% | 1 | Jul 28, 2026 | |
| CAMP Camp4 Therapeutics | Maintained: Buy | $8 | $3.83 | +108.88% | 8 | Jul 27, 2026 | |
| KLRS Kalaris Therapeutics | Maintained: Buy | $17 | $3.65 | +366.39% | 3 | Jul 17, 2026 | |
| VYGR Voyager Therapeutics | Maintained: Buy | $8 | $3.04 | +163.16% | 24 | Jul 14, 2026 | |
| IRD Opus Genetics | Maintained: Buy | $10 | $3.78 | +164.55% | 9 | Jul 9, 2026 | |
| ASND Ascendis Pharma | Rated: Buy | $273 → $327 | $244.01 | +34.01% | 29 | Jul 9, 2026 | |
| SRPT Sarepta Therapeutics | Maintained: Buy | $35 | $15.33 | +128.31% | 30 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 | $17.82 | +90.80% | 21 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $6.78 | +312.98% | 11 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $5 → $6 | $4.77 | +25.79% | 23 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $94 | $60.05 | +56.55% | 16 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 | $9.98 | +60.32% | 15 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $112 → $118 | $133.72 | -11.76% | 28 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $8 | $4.59 | +74.29% | 24 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $28 | $2.90 | n/a | 15 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.81 | n/a | 14 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $38 | $44.42 | n/a | 19 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $27.95 | n/a | 13 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $7.73 | n/a | 13 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $0.3391 | n/a | 9 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $5.10 | n/a | 7 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $105.46 | n/a | 9 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.27 | n/a | 3 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $18.00 | n/a | 2 | Feb 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $23.38 | n/a | 1 | Nov 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $13.15 | n/a | 3 | Jun 28, 2018 |
Rocket Pharmaceuticals
Aug 3, 2026
Maintained: Buy
Price Target: $16
Current: $3.31
Upside: +383.38%
Wave Life Sciences
Jul 31, 2026
Rated: Buy
Price Target: $15 → $12
Current: $5.55
Upside: +116.22%
MannKind
Jul 30, 2026
Maintained: Buy
Price Target: $8
Current: $3.87
Upside: +106.72%
Benitec Biopharma
Jul 28, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $11.72
Upside: +36.52%
Camp4 Therapeutics
Jul 27, 2026
Maintained: Buy
Price Target: $8
Current: $3.83
Upside: +108.88%
Kalaris Therapeutics
Jul 17, 2026
Maintained: Buy
Price Target: $17
Current: $3.65
Upside: +366.39%
Voyager Therapeutics
Jul 14, 2026
Maintained: Buy
Price Target: $8
Current: $3.04
Upside: +163.16%
Opus Genetics
Jul 9, 2026
Maintained: Buy
Price Target: $10
Current: $3.78
Upside: +164.55%
Ascendis Pharma
Jul 9, 2026
Rated: Buy
Price Target: $273 → $327
Current: $244.01
Upside: +34.01%
Sarepta Therapeutics
Jun 30, 2026
Maintained: Buy
Price Target: $35
Current: $15.33
Upside: +128.31%
Jun 22, 2026
Maintained: Buy
Price Target: $34
Current: $17.82
Upside: +90.80%
Jun 22, 2026
Maintained: Buy
Price Target: $28
Current: $6.78
Upside: +312.98%
Jun 3, 2026
Rated: Buy
Price Target: $5 → $6
Current: $4.77
Upside: +25.79%
May 21, 2026
Rated: Buy
Price Target: $94
Current: $60.05
Upside: +56.55%
May 19, 2026
Maintained: Hold
Price Target: $16
Current: $9.98
Upside: +60.32%
May 6, 2026
Rated: Buy
Price Target: $112 → $118
Current: $133.72
Upside: -11.76%
Apr 21, 2026
Downgraded: Hold
Price Target: $8
Current: $4.59
Upside: +74.29%
Mar 30, 2023
Rated: Buy
Price Target: $28
Current: $2.90
Upside: n/a
Mar 30, 2023
Maintained: Hold
Price Target: n/a
Current: $5.81
Upside: n/a
Mar 28, 2023
Rated: Buy
Price Target: $38
Current: $44.42
Upside: n/a
Mar 23, 2023
Reiterated: Buy
Price Target: $4
Current: $27.95
Upside: n/a
Mar 21, 2023
Maintained: Buy
Price Target: $8
Current: $7.73
Upside: n/a
Mar 21, 2023
Maintained: Buy
Price Target: $4
Current: $0.3391
Upside: n/a
Mar 21, 2023
Reiterated: Hold
Price Target: n/a
Current: $5.10
Upside: n/a
Jan 26, 2023
Downgraded: Hold
Price Target: n/a
Current: $105.46
Upside: n/a
May 12, 2020
Reiterated: Buy
Price Target: $10
Current: $1.27
Upside: n/a
Feb 4, 2020
Reiterated: Buy
Price Target: $14
Current: $18.00
Upside: n/a
Nov 12, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $23.38
Upside: n/a
Jun 28, 2018
Downgraded: Hold
Price Target: n/a
Current: $13.15
Upside: n/a